Literature DB >> 11756648

Polymorphisms in the cell wall-spanning domain of the C protein beta-antigen in clinical Streptococcus agalactiae isolates are caused by genetic instability of repeating DNA sequences.

Reinhard Berner1, Michael Ruess, Stefan Bereswill, Matthias Brandis.   

Abstract

The C protein alpha- and beta-antigens are immunodominant components of the surface of Streptococcus agalactiae, the most frequent cause of neonatal sepsis. Both proteins are thought to contribute significantly to virulence of S. agalactiae. They are mainly expressed by serotypes Ia, Ib, and II. The C protein beta-antigen (Cbeta-protein) binds to the Fc portion of human IgA and seems to be of importance in bacterial resistance to mucosal immune defense mechanisms. In this study, PCR analysis of S. agalactiae isolates obtained from 189 neonates and 112 pregnant women revealed the presence of the Cbeta-protein gene in 19% and 22% of the isolates, respectively. Size polymorphisms of the PCR products within the gene region encoding the cell wall-spanning domain indicated a high degree of genetic variability. Thirteen different variants of the amplified region were differentiated among the 60 Cbeta-protein-positive isolates by sequence analysis. In all variants, the polymorphisms were caused by insertions and deletions of repetitive DNA elements that did not alter the open reading frame. Comparison of the Cbeta-protein gene polymorphisms showed a significantly higher rate of isolates carrying deletions >50 bp in serotype Ib than in serotype II isolates (p = 0.001); this was also true for neonatal isolates analyzed separately (p = 0.01). Neonatal isolates carried a higher rate of large deletions when compared with maternal isolates; this difference, however, did not reach statistical significance (p = 0.08). We hypothesize that polymorphisms in the cell wall-spanning domain of the Cbeta-protein are of functional relevance with regard to maternofetal transmission of the pathogen.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11756648     DOI: 10.1203/00006450-200201000-00019

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

Review 1.  Interaction of neonatal phagocytes with group B streptococcus: recognition and response.

Authors:  Philipp Henneke; Reinhard Berner
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

Review 2.  Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.

Authors:  Gunnar Lindahl; Margaretha Stålhammar-Carlemalm; Thomas Areschoug
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Use of phenotypic and molecular serotype identification methods to characterize previously nonserotypeable group B streptococci.

Authors:  Fanrong Kong; Lotte Munch Lambertsen; Hans-Christian Slotved; Danny Ko; Hui Wang; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2008-06-18       Impact factor: 5.948

4.  Inactivation of DNA-binding response regulator Sak189 abrogates beta-antigen expression and affects virulence of Streptococcus agalactiae.

Authors:  Anastasia S Rozhdestvenskaya; Artem A Totolian; Alexander V Dmitriev
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240

5.  A proline-rich region with a highly periodic sequence in Streptococcal beta protein adopts the polyproline II structure and is exposed on the bacterial surface.

Authors:  Thomas Areschoug; Sara Linse; Margaretha Stålhammar-Carlemalm; Lars-Olof Hedén; Gunnar Lindahl
Journal:  J Bacteriol       Date:  2002-11       Impact factor: 3.490

6.  Adjacent location of the bac gene and two-component regulatory system genes within the putative Streptococcus agalactiae pathogenicity island.

Authors:  A Dmitriev; Y H Yang; A D Shen; A Totolian
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.629

Review 7.  Immunogenic Proteins of Group B Streptococcus-Potential Antigens in Immunodiagnostic Assay for GBS Detection.

Authors:  Anna Dobrut; Monika Brzychczy-Włoch
Journal:  Pathogens       Date:  2021-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.